Study of drug prescription pattern among COPD patients admitted to medicine in-patient department of tertiary care hospital
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20173750Keywords:
Bronchodilators, COPD, Drug utilizationAbstract
Background: Drug utilization studies can provide insights into a pattern, quality, determinants and outcomes of drug use. COPD is one of the leading causes of death among Indian population and there is a lack of drug utilization studies in this field.
Methods: A prospective, observational study was conducted among the patients admitted in inpatient department of medicine ward of Tertiary care hospital. Data has collected from COPD patients admission records. Parameters like demographic profile, common associated diseases, WHO core drug indicators and commonly prescribed drugs were assessed from the prescriptions.
Results: A total 284 inpatient records were scrutinized. Out of 284 patients, 66.19% were male and 33.80% were female. Average numbers of drugs per prescription were 7. Mean age was 66.9 years. Antimicrobials (88.7%) were most commonly prescribed drugs followed by inhaled bronchodilators (84.5%).
Conclusions: Study data highlights that average numbers of drugs prescribed were higher than WHO norms, antibiotics were commonly used, and drugs prescribed with brand names were higher than the generic names.
References
World Health Organisation. Introduction to Drug Utilization Research. Geneva. World Health Organisation; 2003. Available at: http://www.apps.who.int/medicinedocs/en/d/Js4876e. [Last accessed on 2016 Dec 08].
Koul P. Chronic obstructive pulmonary disease: Indian guidelines and the road ahead. Lung India. 2013;30(3):175.
World Health Organisation. Chronic obstructive pulmonary disease (COPD). Geneva. World Health Organisation; 2016. Available at: http://www.who.int/topics/chronic_obstructive_pulmonary_disease/en/. [Last accessed on 2016 Nov 13].
John J, Reilly J, Silverman EK, Shapiro SD. Chronic Obstructive Pulmonary Disease. Harrisons principles of internal medicine. 18th Ed. New York: McGraw-Hill; 2012:2151-2160.
Chaturvedi R, Muzammil K, Singh N, Davey S, Singh JV. Prevalence of COPD in rural population, Muzaffarnagar. Indian J Community Heal. 2015;27(4):468-72.
Jindal SK. COPD: The unrecognized epidemic in India. J Assoc Physicians India. 2012;60:14-6.
Unni A, Jayaprakash AK, Mc Y, P UMAD. Innovare Academic Sciences Short Communication Drug Utilization Pattern In Chronic Obstructive Pulmonary Disease Inpatients at a Tertiary Care Hospital. IJPP. 2015;7(11):80-2.
Nm A, Shakeel M, Bashir M, Ali A. A Cross-Sectional Study on Prescribing Patterns on Patients Suffering from Respiratory Disorders in a Teaching Hospital of South India. J Cont Med A Dent. 2014;2(1):12-7.
World Health Organisation. Rational use of medicines. Geneva. World Health Organisation; 2016. Available at: http://apps.who.int/medicinedocs/en/d/Js6160e/10.html. /. [Last accessed on 2016 Nov 17].
Shinde RM, Kale A, Chube S, Sawant M. Drug utilization study in medical intensive care unit in a rural tertiary care teaching hospital in Maharashtra. Int J Med Sci Public Health, [cited December 22, 2016]; Online First: 21 Dec, 2016.
Veettil SK, Rajiah K, Kumar S. Study of Drug Utilization Pattern for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients Attending a Government Hospital in Kerala, India. Journal of Family Medicine and Primary Care. 2014;3(3):250-4.
Wilson R. Treatment of COPD exacerbations: antibiotics. European Respiratory Review. 2005;14(94):32-8.
Ko F, Chan K, Hui D, Goddard J, Shaw J, Reid D, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152-65.
Gupta D, Agarwal R, Aggarwal AN, Maturu VN, Dhooria S, Prasad KT, et al. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS / NCCP (I) recommendations. Lung India. 2013;30(3):228-67.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). GOLD 2017 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2017 report. Page no. 31-36. Available at: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-preve. Accessed December 08, 2016.
